SecBot SecBot
144 ·Filed Nov 4, 2026

LGND

LIGAND PHARMACEUTICALS INC
NEUTRAL
Impact 1/10
Horizondays Processed12d 9h ago SEC0001957799-26-000193
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The sale is de minimis for a director and likely routine portfolio management. Monitor for any larger insider sales or changes in director holdings in future filings.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$299.00
T+0 close · Nov 4, 2026 · via day close
Latest settled
+5.78%
T+5 · $316.27 · next T+20 in 17d
Vs SPY
+2.49%
α at T+5
Latest observation
+1.82%
T+6 · FF3 residual α
  1. T+0 · Nov 5 $299.00entry
  2. T+1 · 11d ago +2.41%α +2.10% · $306.20
  3. T+5 · 5d ago +5.78%α +2.49% · $316.27
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Director Jason Aryeh filed a Form 144 on November 4, 2026, indicating intent to sell 282 shares of Class B common stock, with an approximate market value of $90,225.50 based on the filing date price. The shares were acquired in 2019 via secondary market purchases. This is a very small sale relative to the company's $6.1B market cap and the insider's apparent holdings, and carries minimal signal.

Key Facts

  • Insider: Jason Aryeh, Director of Ligand Pharmaceuticals
  • Shares to be sold: 282 shares of Class B common stock
  • Approximate value: $90,225.50 (based on filing date price of ~$320/share)
  • Shares acquired: between May 14, 2019 and July 30, 2019 via secondary market purchase
  • Broker: Wells Fargo Clearing Services
  • Sale intended on or after November 4, 2026 on Nasdaq
  • Insider also reported additional holdings acquired on Oct 30, 2026 (1,209 shares) and Nov 2, 2026 (700 shares), total recent acquisitions ~2,111 shares

Financial Impact

Proposed sale of 282 shares worth ~$90K, representing less than 0.002% of market cap

dilution

Risk Factors

  • Form 144 is only an intent to sell; the sale may not occur
  • No material risk to shareholders from this small proposed sale

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
94% bullish (17 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001957799-26-000193
Document: 0001957799-26-000193-index.html0001957799-26-000193
Document: 0001957799-26-000193.txt0001957799-26-000193

Track record

29 reports on LGND

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +38.85% at T+60 after the Apr 14, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $305.74 Now $301.71 −1.32% settles Feb 16
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $306.47 Now $301.71 −1.55% settles Feb 12
  3. Nov 12, 20264d ago 144 Neutral 2/10 Entry $308.79 Now $301.71 −2.29% settles Feb 11
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $308.79 Now $301.71 −2.29% settles Feb 11
  5. Nov 12, 20264d ago 144 Neutral 2/10 Entry $316.27 Now $301.71 −4.60% settles Feb 10
  6. Nov 10, 20266d ago SC 13G/A Neutral 2/10 Entry $316.83 Now $301.71 −4.77% settles Feb 9
  7. Nov 10, 20266d ago 144 Neutral 2/10 Entry $314.16 Now $301.71 −3.96% settles Feb 8
  8. Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $314.15 Now $301.71 −3.96% settles Feb 5
  9. Nov 4, 202612d ago 144 Neutral 1/10 Viewing Entry $299.00 Now $301.71 +0.91% settles Feb 3
  10. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $299.00 Now $301.71 +0.91% settles Feb 3
Showing 10 of 29

US Market Status

Market Closed · Opens in 7h 46m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026